Aaron Kantoff - Director at Avalo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
AVTX on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Aaron Kantoff since 11/23/2023

Holdings reported by Aaron Kantoff for Avalo Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 9.5K $4.93K $0.52 Aug 13, 2024 Direct Common Stock
Stock Option (Right to Buy) 24.6K Aug 13, 2024 Direct Common Stock

Transactions reported by Aaron Kantoff for Avalo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.